SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-014223
Filing Date
2019-05-20
Accepted
2019-05-20 20:21:28
Documents
1
Period of Report
2019-05-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4075
  Complete submission text file 0000899243-19-014223.txt   5593
Mailing Address 44 WHIPPANY ROAD MORRISTOWN NJ 07963
Business Address 44 WHIPPANY ROAD MORRISTOWN NJ 07963 908 617-1309
MELINTA THERAPEUTICS, INC. /NEW/ (Issuer) CIK: 0001461993 (see all company filings)

IRS No.: 454440364 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 1650 TYSONS BOULEVARD SUITE 1700 MCLEAN VA 22102
Business Address
Milligan Peter J (Reporting) CIK: 0001531049 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35405 | Film No.: 19840568